Focal areas of pneumonia that affected 10+/-3% of the total lung surface area was observed in control animals on day 28 of infection, while treated mice did not show pneumonia, probably as a consequence of the high bacterial elimination produced by the HMGB1 blocking antibodies administration (Fig 3C–3F). This evidence concerns the gene HMGB1 and susceptibility to pneumonia measurement.